On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Niall Stanage chats with The Hill’s Mychael Schnell as President Elect Trump’s nominees face tough questions in the Senate. Mychael has the latest on the confirmations plus the details of Biden’s ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.

Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

TD Cowen analysts estimate that about 45% of U.S. sales for Ozempic and Rybelsus each goes through Medicare Part D.

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they ...

The Biden administration announced Friday that popular weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations with manufacturers.

Biden administration selects 15 new medications up for price negotiations including weight loss drugs Ozempic and Wegovy.